Matthew G. Wyckoff
Oprichter bij Aceras BioMedical LLC
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Daniel DiPietro | M | - |
Aceras BioMedical LLC
 Aceras BioMedical LLC Investment ManagersFinance Aceras BioMedical LLC (Aceras BioMedical) is a porivate equity/venture capital firm founded in 2008 by Peter barber, Matthew Wyckoff, and Daniel DiPietro. The firm is headquartered in New York, New York. | 16 jaar |
| Peter H. Barber | M | - |
Aceras BioMedical LLC
Aceras BioMedical LLC Investment ManagersFinance Aceras BioMedical LLC (Aceras BioMedical) is a porivate equity/venture capital firm founded in 2008 by Peter barber, Matthew Wyckoff, and Daniel DiPietro. The firm is headquartered in New York, New York. | 16 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Richard Stewart | M | 65 |
Huxley Pharmaceuticals, Inc.
 Huxley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioMarin Pharmaceutical, Inc., Huxley Pharmaceuticals, Inc. is a company that develops biochemical products. Huxley Pharmaceuticals, Inc. is based in Huxley, IA. Huxley Pharmaceuticals was acquired by BioMarin Pharmaceutical, Inc. on October 26, 2009 for $81 million. The company was founded by Matthew G. Wyckoff. | - |
| John Liatos | M | 56 |
Aceras BioMedical LLC
Aceras BioMedical LLC Investment ManagersFinance Aceras BioMedical LLC (Aceras BioMedical) is a porivate equity/venture capital firm founded in 2008 by Peter barber, Matthew Wyckoff, and Daniel DiPietro. The firm is headquartered in New York, New York. | - |
| Anthony Clarke | M | 68 |
Huxley Pharmaceuticals, Inc.
Huxley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioMarin Pharmaceutical, Inc., Huxley Pharmaceuticals, Inc. is a company that develops biochemical products. Huxley Pharmaceuticals, Inc. is based in Huxley, IA. Huxley Pharmaceuticals was acquired by BioMarin Pharmaceutical, Inc. on October 26, 2009 for $81 million. The company was founded by Matthew G. Wyckoff. | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 5 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Matthew G. Wyckoff
- Persoonlijk netwerk
